Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Highlights

A collection of news and information related to Vertex Pharmaceuticals Incorporated published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-10 of 10
» View wsbtradio.com items only
    May 8, 2013 |Story| Reuters
  1. Many in U.S. don't get proper testing for hepatitis C- CDC

    Reuters
    By Julie Steenhuysen NEW YORK, May 8 (Reuters) - Only half of people in the United States who have ever been infected with hepatitis C get proper testing for the liver-destroying disease, according to U.S. health officials. Proper testing is a two-...

    Tags: U.S. Centers for Disease Control and Prevention, Diseases and Illnesses, Hepatitis, Disease Prevention, Viral Diseases and Infections

  2. May 2, 2013 |Story| South Florida Sun-Sentinel
  3. International consortium releases hepatitis C data

    Two antiviral drugs used to treat hepatitis C appear to work as well in the real world as they did during clinical trials, an international research consortium has observed. The consortium also released data that may help inform how doctors and patients...

    Tags: Liver Failure, University of North Carolina at Chapel Hill, Education, National Institutes of Health, Liver Disease

  4. May 1, 2013 |Story| Reuters
  5. U.S. RESEARCH ROUNDUP: Berkshire, Fortinet, Aetna, NextEra Energy

    Reuters
    May 1 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies including Berkshire Hathaway, Aetna and Fortinet Inc on Wednesday. HIGHLIGHTS * Aetna Inc : Credit Suisse, Jefferies, Susquehanna, others...

    Tags: Big Lots Incorporated, Technology, Arthur J. Gallagher & Company, Franklin Resources Incorporated, Berkshire Hathaway Inc.

  6. Apr 30, 2013 |Story| Reuters
  7. Vertex posts quarterly loss as hepatitis C drug sales fall

    Reuters
    April 30 (Reuters) - Vertex Pharmaceuticals Inc on Tuesday reported a fourth successive quarterly loss as sales of its hepatitis C drug, Incivek, continued to plunge, but the biotechnology company raised its forecast for sales of a cystic fibrosis drug...

    Tags: Biotechnology Industry, Hepatitis C , Biotechnology, Chemical Industry, Science and Technology

  8. Apr 28, 2013 |Story| Hartford Courant
  9. READER SUBMITTED: American Liver Foundation's Raises $242,000 At Twelfth Annual Flavors Of Connecticut

    Statewide
    The American Liver Foundation (ALF), a non-profit organization focused on promoting liver health and disease prevention held its annual fundraising event, Flavors of Connecticut presented by Hartford Hospital. The event took place on April 9 at the Aqua...

    Tags: Auction Service, Diseases and Illnesses, Disease Prevention, Bars and Clubs, Salix Pharmaceuticals Limited

  10. Aug 27, 2012 |Story| WDBJ7
  11. OUR HEALTH: New Hepatitis C Treatment Clinic Brings Specialized Treatment to Local Patients

    Anewly formed infectious disease clinic in Lynchburg, VA is bringing expert medical care to those in the area with hepatitis C.
    Anewly formed infectious disease clinic in Lynchburg, VA is bringing expert medical care to those in the area with hepatitis C. An estimated 3.2 million people in the United States have a chronic hepatitis C viral infection. Most of them don’t even...

    Tags: Recreational Substance Use, Blood Transfusion, Hepatitis, AIDS, National Institutes of Health

  12. May 18, 2012 |Story| AP Broadcast
  13. CDC to baby boomers: Get tested for hepatitis C

    ATLANTA (AP) — For the first time, the government is proposing that all baby boomers get tested for hepatitis C. Anyone born from 1945 to 1965 should get a one-time blood test to see if they have the liver-destroying virus, the Centers for...

    Tags: Emergency Health Procedures, U.S. Centers for Disease Control and Prevention, Diseases and Illnesses, Disease Prevention, Hepatitis

  14. Feb 21, 2012 |Story| Petoskey News
  15. Hepatitis C deaths up, baby boomers most at risk

    WASHINGTON (AP)— Deaths from liver-destroying hepatitis C are on the rise, and new data shows baby boomers especially should take heed — they are most at risk.
    WASHINGTON (AP)— Deaths from liver-destroying hepatitis C are on the rise, and new data shows baby boomers especially should take heed — they are most at risk. Federal health officials are considering whether anyone born between 1945 and 1965...

    Tags: Blood Transfusion, Hepatitis, Human Body, AIDS, Health and Medical Professionals

  16. Nov 2, 2011 |Story| Los Angeles Times
  17. Cystic fibrosis drug ivacaftor offers patients new hope

    All her life, Lindsay Shipp knew that she was dying. As a baby, she would cry after eating, and salt collected on her forehead. The diagnosis was cystic fibrosis, an incurable genetic disease that, at the time, meant a life expectancy of 18 years.
    All her life, Lindsay Shipp knew that she was dying. As a baby, she would cry after eating, and salt collected on her forehead. The diagnosis was cystic fibrosis, an incurable genetic disease that, at the time, meant a life expectancy of 18 years. The...

    Tags: Diseases and Illnesses, Lungs and Airways, Music, Entertainment, University of Iowa

  18. May 23, 2011 |Story| Reuters
  19. Vertex Hepatitis-C Drug OK'd, Promising More Cures

    Vertex Pharmaceuticals Inc's highly anticipated hepatitis C drug won U.S. approval, promising far higher cure rates for the liver-destroying disease and setting up a head-to-head marketing battle with a rival new medicine from Merck & Co.
    Reuters
    Vertex Pharmaceuticals Inc's highly anticipated hepatitis C drug won U.S. approval, promising far higher cure rates for the liver-destroying disease and setting up a head-to-head marketing battle with a rival new medicine from Merck & Co. Incivek, a pill...

    Tags: Diseases and Illnesses, Hepatitis, Human Body, Health, Blood

Original site for Vertex Pharmaceuticals Incorporated topic gallery.